Antiviral Effects of Menthol on Coxsackievirus B.
Animals
Antiviral Agents
/ pharmacology
Cells, Cultured
Coxsackievirus Infections
/ drug therapy
Disease Models, Animal
Enterovirus B, Human
/ drug effects
Gene Expression
Genes, Reporter
Genetic Vectors
/ genetics
HeLa Cells
Host-Pathogen Interactions
/ drug effects
Humans
Menthol
/ pharmacology
Mice
TRPM Cation Channels
/ agonists
TRPV Cation Channels
/ antagonists & inhibitors
Temperature
Virus Replication
/ drug effects
antiviral
coxsackievirus
menthol
mitochondria
pancreas
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
28 03 2020
28 03 2020
Historique:
received:
16
03
2020
revised:
24
03
2020
accepted:
25
03
2020
entrez:
2
4
2020
pubmed:
2
4
2020
medline:
17
2
2021
Statut:
epublish
Résumé
Coxsackievirus B (CVB) is a common human enterovirus that causes systemic infection but specifically replicates to high titers in the pancreas. It was reported that certain viruses induce mitochondrial fission to support infection. We documented that CVB triggers mitochondrial fission and blocking mitochondrial fission limits infection. The transient receptor potential channels have been implicated in regulating mitochondrial dynamics; namely, the heat and capsaicin receptor transient receptor potential cation channel subfamily V member 1 (TRPV1) contributes to mitochondrial depolarization and fission. When we transiently warmed HeLa cells to 39 °C prior to CVB exposure, infection was heightened, whereas cooling cells to 25 °C reduced infection. Inducing "cold" by stimulating transient receptor potential cation channel subfamily M member 8 (TRPM8) with menthol led to reduced infection and also resulted in lower levels of mitochondrial fission during infection. Additionally, menthol stabilized levels of mitochondrial antiviral signaling (MAVS) which is known to be tied to mitochondrial dynamics. Taken together, this highlights a novel pathway wherein CVB relies on TRPV1 to initiate proviral mitochondrial fission, which may contribute to the disruption of antiviral immunity. TRPM8 has been shown to antagonize TRPV1, and thus we hypothesize that stimulating TRPM8 blocks TRPV1-mediated mitochondrial fragmentation following CVB exposure and attenuates infection.
Identifiants
pubmed: 32231022
pii: v12040373
doi: 10.3390/v12040373
pmc: PMC7232514
pii:
doi:
Substances chimiques
Antiviral Agents
0
TRPM Cation Channels
0
TRPM8 protein, human
0
TRPV Cation Channels
0
TRPV1 protein, human
0
Menthol
1490-04-6
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : P01 CA233452
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI145356
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI154927
Pays : United States
Organisme : NIH HHS
ID : R21 AI145356
Pays : United States
Références
PLoS One. 2017 Feb 10;12(2):e0171681
pubmed: 28187208
J Med Virol. 2000 Sep;62(1):70-81
pubmed: 10935991
J Virol. 2004 Aug;78(15):8229-37
pubmed: 15254194
Scand J Gastroenterol. 1976;11(7):645-9
pubmed: 996429
J Virol. 2002 May;76(9):4430-40
pubmed: 11932410
Viral Immunol. 2004;17(3):358-69
pubmed: 15357902
J Biomed Sci. 2018 Nov 30;25(1):87
pubmed: 30501621
Cell Metab. 2016 Mar 8;23(3):399-401
pubmed: 26959181
Glia. 2015 Oct;63(10):1870-82
pubmed: 26010461
Curr Opin Pharmacol. 2009 Jun;9(3):243-9
pubmed: 19269247
Recent Pat CNS Drug Discov. 2006 Jan;1(1):65-76
pubmed: 18221192
Acta Neuropathol. 2015 Jan;129(1):81-96
pubmed: 25322817
J Clin Gastroenterol. 2003 Aug;37(2):169-72
pubmed: 12869890
J Neurosci. 2013 Mar 27;33(13):5603-11
pubmed: 23536075
J Virol. 2017 Nov 30;91(24):
pubmed: 28978702
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6413-8
pubmed: 24733894
Can J Surg. 2006 Apr;49(2):101-6
pubmed: 16630420
Cells. 2013 Jan 25;2(1):83-104
pubmed: 24709646
Phytomedicine. 2003;10(6-7):504-10
pubmed: 13678235
EMBO Rep. 2010 Feb;11(2):133-8
pubmed: 20019757
Neural Plast. 2016;2016:1568145
pubmed: 26881090
J Physiol Sci. 2016 Mar;66(2):143-55
pubmed: 26645885
J Virol. 2010 Dec;84(23):12110-24
pubmed: 20861268
J Pathol. 2010 May;221(1):3-12
pubmed: 20225336
Biochem Biophys Res Commun. 2017 Mar 11;484(3):550-556
pubmed: 28131843
PLoS Pathog. 2013;9(12):e1003722
pubmed: 24339771
PLoS Pathog. 2014 Apr 10;10(4):e1004045
pubmed: 24722773
FASEB J. 2014 Feb;28(2):891-6
pubmed: 24221085
Biol Chem. 2012 Jul;393(7):547-64
pubmed: 22944659
Virology. 2019 Mar;529:169-176
pubmed: 30711774
Gastroenterology. 2011 Apr;140(4):1283-1291.e1-2
pubmed: 21185837
J Cell Biol. 2010 Dec 27;191(7):1367-80
pubmed: 21173115
Clin Endosc. 2014 May;47(3):212-6
pubmed: 24944983
Mol Biol Cell. 2018 Dec 15;29(26):3082-3092
pubmed: 30354903
Biomed Environ Sci. 2018 Dec;31(12):867-875
pubmed: 30636656
N Engl J Med. 2006 May 18;354(20):2142-50
pubmed: 16707751
PLoS Pathog. 2011 Mar;7(3):e1001311
pubmed: 21436888
JOP. 2004 Sep 10;5(5):384-7
pubmed: 15365208